NCT00225186View on ClinicalTrials.gov

Safety and Efficacy of SH T00660AA in Treatment of Endometriosis

PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Endometriosis
Interventions
DRUG

Visanne (SH T00660AA , BAY86-5258)

Daily long-term drug treatment (12 months), and post-treatment observation (6 months) in a subgroup of patients

Trial Locations (28)

10127

Torino

17487

Greifswald

21000

Vinnitsa

23538

Lübeck

25123

Brescia

35392

Giessen

39624

Kalbe

48129

Münster

52074

Aachen

58017

Chernivtsi

58285

Gevelsberg

63165

Mühlheim am Main

69115

Heidelberg

72076

Tübingen

80138

Napoli

81241

München

86381

Krumbach

90419

Nuremberg

01744

Dippoldiswalde

04103

Leipzig

09496

Marienberg

01474

Weißig

09042

Cagliari

00165

Roma

01030

Kiev

04050

Kiev

04107

Kiev

04210

Kiev

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY